The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...

The UK and Europe markets experienced a relatively soft quarter due to seasonality, impacting overall growth in these regions. Capacity utilization at the Teva facility is currently at 40%, indicating ...

Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. Alvotech's ...

Opioid Withdrawal Treatment market Rising Trends, Demand and Future Scope 2025 to 2034 ...

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and ...

A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...

Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ: NATR), a leading manufacturer of high-quality herbal and ...

The Danish pharma company plans to launch Neffy in Europe in 2025, whilst a regulatory approval application ... along with ...

The global auto-injectors market is set to reach a significant valuation of US$ 30,578.2 million in 2023, marking a strong ...